These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7017869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I, Rosenthal J.
    Dtsch Med Wochenschr; 1978 Nov 10; 103(45):1790-6. PubMed ID: 710289
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A, Deschodt G, Barjon P, Mary H, Thevenet A.
    Nouv Presse Med; 1978 Dec 02; 7(43):3889-93. PubMed ID: 733540
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of angiotensin II analogue on rabbits with acute and chronic two-kidney, one clip hypertension (author's transl)].
    Yamasaki S, Nakatani H, Kusunoki K, Kawashima T, Kawamura H, Ohara T, Shintani H, Taniguchi N, Nagai T.
    Nihon Jinzo Gakkai Shi; 1979 Nov 02; 21(11):1251-63. PubMed ID: 396405
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 02; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Nov 02; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

  • 11. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension].
    Rosenthal J, Franz HE.
    Verh Dtsch Ges Inn Med; 1976 Nov 02; 82 Pt 2():1305-7. PubMed ID: 1029984
    [No Abstract] [Full Text] [Related]

  • 12. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK, Williams GH, Adams DF, Moore T, Brown C, Borucki LJ, Leung F, Bavli S, Solomon HS, Passan D, Dluhy R.
    Medicine (Baltimore); 1979 Mar 02; 58(2):115-27. PubMed ID: 431398
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K, Yagihashi Y, Kogawa T, Kawamata A, Yamaya K, Sugawara S, Tulachan Y, Funyu T, Eba H, Kido K, Tanaka T, Morita S, Fukushi M, Furusawa M, Terayama Y, Hirayama N.
    Nihon Jinzo Gakkai Shi; 1979 Nov 02; 21(11):1231-42. PubMed ID: 396404
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R, Amery A, Ljnen P, Reybrouck T, Billiet L.
    Prog Biochem Pharmacol; 1976 Nov 02; 12():242-9. PubMed ID: 1019167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.